Not applicableWithdrawnNCT02225795What this trial is testingPilot Study of Stem Cell Transplantation for Children and Young Adults With Refractory Crohn's Disease.Who this might be right forCrohn's Disease TriStar Health
Testing effectiveness (Phase 2)Study completedNCT00002522What this trial is testingCombination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's LymphomaWho this might be right forLymphoma Temple University
Large-scale testing (Phase 3)Study completedNCT00109031What this trial is testingPalifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE)Who this might be right forCancerLymphomaLeukemia Swedish Orphan Biovitrum 47
Not applicableUnknownNCT04021875What this trial is testingThe Effects of Autologous SLETWho this might be right forLimbal Stem-cell Deficiency National Taiwan University Hospital 30
Testing effectiveness (Phase 2)WithdrawnNCT03608501What this trial is testingIxazomib, Thalidomide and Dexamethasone in Newly Diagnosed and Treatment-naive Multiple Myeloma (MM) Participants Non-eligible for Autologous Stem-cell TransplantationWho this might be right forMultiple Myeloma Takeda
Early research (Phase 1)UnknownNCT03067870What this trial is testingTransplantation of Autologous Bone Marrow Derived Stem Cells in Patients With Rheumatoid ArthritisWho this might be right forRheumatoId ArthritisOsteoarthritis, KneeOsteoarthritis, Hip Stem Cells Arabia 100
Large-scale testing (Phase 3)Study completedNCT00083876What this trial is testingD.T. PACE Versus High Dose Melphalan and Autologous Transplant in Patients With Previously Treated Multiple MyelomaWho this might be right forMultiple Myeloma University of Arkansas 500
Testing effectiveness (Phase 2)Study completedNCT04478123What this trial is testingUsing Romiplostim to Treat Low Platelet Counts Following Chemotherapy and Autologous Hematopoietic Cell Transplantation in People With Blood CancerWho this might be right forMultiple MyelomaHodgkin LymphomaNon-Hodgkin Lymphoma+1 more Memorial Sloan Kettering Cancer Center 62
Early research (Phase 1)Study completedNCT00020410What this trial is testingRadiolabeled Monoclonal Antibody Followed by Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Metastatic Breast CancerWho this might be right forBreast Cancer National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT00800059What this trial is testingTotal Marrow Irradiation & Autologous Stem Cell Transplantation for Relapsed or Refractory MyelomaWho this might be right forMultiple Myeloma Ottawa Hospital Research Institute 27
Early research (Phase 1)Looking for participantsNCT06647979What this trial is testingHematopoietic Stem Cell BCL11A Enhancer Gene Editing for Severe β-HemoglobinopathiesWho this might be right forSickle Cell DiseaseSickle Cell Anemia (HbSS, or HbSβ-thalassemia0)Beta-Thalassemia+1 more Daniel Bauer 10
Testing effectiveness (Phase 2)Study completedNCT00992446What this trial is testingBortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant in Treating Patients With Non-Hodgkin LymphomaWho this might be right forAdult Diffuse Large B-Cell LymphomaB-Cell Non-Hodgkin LymphomaFollicular Lymphoma+3 more Fred Hutchinson Cancer Center 27
Testing effectiveness (Phase 2)Ended earlyNCT00847223What this trial is testingEfficacy and Safety of the Farnesyl-transferase Inhibitor (Tipifarnib) in Mantle Cell LymphomaWho this might be right forMantle Cell Lymphoma Lymphoma Study Association 11
Testing effectiveness (Phase 2)UnknownNCT00378755What this trial is testingSequential VAD and VTD Followed by HDT With ASCT and Velcade Maintenance for NDMMWho this might be right forMultiple Myeloma Korean Multiple Myeloma Working Party 62
Testing effectiveness (Phase 2)Study completedNCT01718743What this trial is testingIxazomib Citrate and Lenalidomide After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple MyelomaWho this might be right forHematopoietic Cell Transplantation RecipientPlasma Cell Myeloma M.D. Anderson Cancer Center 64
Not applicableStudy completedNCT04419038What this trial is testingEvaluation of Conjunctival Autografting With MMC Application Versus Ologen Implantation of Recurrent PterygiumWho this might be right forRecurrent Pterygium of Eye Menoufia University 63
Not applicableLooking for participantsNCT06463717What this trial is testingPrimary Multiple Myeloma Who Achieved MRD Negativity After Induction Therapy, ASCT or NotWho this might be right forMultiple MyelomaMinimal Residual Disease First Affiliated Hospital of Zhejiang University 210
Post-approval studies (Phase 4)Study completedNCT06425276What this trial is testingEvaluate Safety and Efficacy of High-dose Melphalan HCL for Injection in MM Patients With Auto-HSC TransplantationWho this might be right forMultiple Myeloma CASI Pharmaceuticals (China) Co., Ltd. 67
Large-scale testing (Phase 3)Active Not RecruitingNCT04293185What this trial is testingA Study Evaluating Gene Therapy With BB305 Lentiviral Vector in Sickle Cell DiseaseWho this might be right forSickle Cell Disease Genetix Biotherapeutics Inc. 35
Large-scale testing (Phase 3)Study completedNCT00950768What this trial is testingMelphalan 200 mg/m2 Versus Melphalan 100 mg/m2 in Newly Diagnosed Myeloma PatientsWho this might be right forMultiple MyelomaDiagnosis Azienda Ospedaliera San Giovanni Battista 298